Back to top
more

Arcadia Biosciences (RKDA)

(Delayed Data from NSDQ)

$4.60 USD

4.60
2,042

+0.15 (3.37%)

Updated Aug 6, 2025 10:03 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (144 out of 246)

Industry: Medical - Biomedical and Genetics

Zacks News

Zacks Equity Research

Arcadia Biosciences to Merge With Roosevelt, Shares Surge 105%

RKDA inks deal with Roosevelt to become a new entity, Roosevelt Resources, with Roosevelt as the majority shareholder.

Zacks Equity Research

Arcadia Biosciences' Q3 Earnings Miss Estimates, Sales Increase Y/Y

RKDA witnesses a solid 55% improvement in Zola sales in Q3. The company continues to invest to grow the Zola brand.

Zacks Equity Research

GrowGeneration Earnings Miss Estimates in Q3, Revenues Dip Y/Y

GRWG expects revenues between $190 million and $195 million for 2024.

Zacks Equity Research

Arcadia Biosciences (RKDA) Reports Q3 Loss, Tops Revenue Estimates

Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of -12.99% and 9.94%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Hydrofarm Holdings Group, Inc. (HYFM) Reports Q3 Loss, Lags Revenue Estimates

Hydrofarm (HYFM) delivered earnings and revenue surprises of -13.04% and 6.36%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Zacks Industry Outlook Highlights Bunge, West Fraser Timber, Hydrofarm and Arcadia Biosciences

Bunge, West Fraser Timber, Hydrofarm and Arcadia Biosciences have been highlighted in this Industry Outlook article.

Madhurima Das headshot

4 Agriculture - Products Stocks to Watch Despite Industry Concerns

The near-term outlook for the Zacks Agriculture - Products industry is uncertain due to low commodity prices and inflated costs. Investors should watch BG, WFG, HYFM and RKDA, which are braving the industry headwinds.

Zacks Equity Research

Arcadia Biosciences (RKDA) Q2 Earnings Miss, Increase Y/Y

Arcadia Biosciences (RKDA) witnesses a solid 42% improvement in Zola sales in Q2. The company continues to invest to grow the Zola brand through mass market retailers and grocery store chains.

Zacks Equity Research

Arcadia Biosciences (RKDA) Q2 Earnings Miss Estimates

Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of -38.58% and 37.47%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Hydrofarm Holdings Group, Inc. (HYFM) Reports Q2 Loss, Tops Revenue Estimates

Hydrofarm (HYFM) delivered earnings and revenue surprises of -21.74% and 3.38%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Arcadia Biosciences (RKDA) Upgraded to Strong Buy: Here's What You Should Know

Arcadia Biosciences (RKDA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks Equity Research

Arcadia Biosciences (RKDA) Sells GoodWheat Brand to Above Food

Arcadia Biosciences (RKDA) sells its GoodWheat brand to scale up its wheat IP.

Zacks Equity Research

Arcadia Biosciences (RKDA) Shares Gain on Q1 Earnings Beat

Arcadia Biosciences' (RKDA) Q1 results benefit from a decline in operating expenses.

Zacks Equity Research

Arcadia Biosciences (RKDA) Reports Q1 Loss, Tops Revenue Estimates

Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 29.37% and 4.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

New Strong Sell Stocks for April 22nd

AMN, PRG and RKDA have been added to the Zacks Rank #5 (Strong Sell) List on April 22, 2024.

Zacks Equity Research

Arcadia Biosciences (RKDA) Q4 Earnings Beat Mark, Sales Up Y/Y

Arcadia Biosciences (RKDA) reports improved top-line results in the fourth quarter of 2023, which is aided by higher GoodWheat and GLA revenues.

Zacks Equity Research

Arcadia Biosciences (RKDA) Reports Q4 Loss, Misses Revenue Estimates

Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 7.46% and 35%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Zacks Industry Outlook Highlights like West Fraser Timber, CalMaine Foods, GrowGeneration, Hydrofarm and Arcadia Biosciences

West Fraser Timber, CalMaine Foods, GrowGeneration, Hydrofarm and Arcadia Biosciences are part of the Zacks Industry Outlook article.

Madhurima Das headshot

5 Agriculture - Products Stocks to Watch in a Challenging Industry

The Zacks Rank for the Agriculture - Products industry paints a gloomy picture. Investors should keep an eye on these five stocks braving the industry headwinds -- West Fraser (WFG), CalMaine Foods (CALM), GrowGeneration (GRWG), Hydrofarm (HYFM) and Arcadia Biosciences (RKDA).

Zacks Equity Research

Zacks Industry Outlook Highlights Bunge, The Andersons and Arcadia Biosciences

Bunge, The Andersons and Arcadia Biosciences have been highlighted in this Industry Outlook article.

Madhurima Das headshot

3 Agriculture - Products Stocks to Watch in a Promising Industry

The Agriculture - Products industry is set to gain from solid demand. Stocks like Bunge (BG), Andersons (ANDE) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.

Zacks Equity Research

GrowGeneration (GRWG) Reports Q3 Loss, Tops Revenue Estimates

GrowGeneration (GRWG) delivered earnings and revenue surprises of -9.09% and 1.29%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

New Strong Buy Stocks for October 25th

RKDA, GHRS, GPS, RITM and EXAI have been added to the Zacks Rank #1 (Strong Buy) List on October 25, 2023.

Zacks Equity Research

New Strong Buy Stocks for October 17th

MNTX, PGNY, GFF, RKDA and CYCC have been added to the Zacks Rank #1 (Strong Buy) List on October 17, 2023.